Comments
Loading...
RenovoRx (RNXT) Forecast
NewsEarningsRenovoRx (RNXT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRenovoRx (NASDAQ:RNXT) Stock Quotes, Forecast and News Summary
RenovoRx Stock (NASDAQ: RNXT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy RenovoRx (RNXT) stock?
You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.
Who are RenovoRx (RNXT) competitors?
Other companies in RenovoRx’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Intensity Therapeutics (NASDAQ:INTS), Curis (NASDAQ:CRIS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for RenovoRx (RNXT) stock?
RenovoRx has a consensus price target of $8.67.
What is the current price for RenovoRx (RNXT)?
The stock price for RenovoRx (NASDAQ: RNXT) is $1.27 last updated December 18, 2024 at 1:31 PM EST.
Does RenovoRx (RNXT) pay a dividend?
There are no upcoming dividends for RenovoRx.
When is RenovoRx (NASDAQ:RNXT) reporting earnings?
RenovoRx’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is RenovoRx (RNXT) going to split?
There is no upcoming split for RenovoRx.
What sector and industry does RenovoRx (RNXT) operate in?
RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.